Targeting PI3K/mTOR Signaling in Cancer.

Arcaro, Alexandre (2014). Targeting PI3K/mTOR Signaling in Cancer. Frontiers in oncology, 4, p. 84. Frontiers Research Foundation 10.3389/fonc.2014.00084

[img]
Preview
Text
Paper 4 Arcaro.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).

Download (363kB) | Preview

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Paediatric Medicine
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Hämatologie / Onkologie (Pädiatrie)
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Hämatologie / Onkologie (Pädiatrie)

UniBE Contributor:

Arcaro, Alexandre

Subjects:

600 Technology > 610 Medicine & health

ISSN:

2234-943X

Publisher:

Frontiers Research Foundation

Language:

English

Submitter:

André Schaller

Date Deposited:

05 Feb 2015 11:50

Last Modified:

20 Sep 2017 07:09

Publisher DOI:

10.3389/fonc.2014.00084

PubMed ID:

24795861

Uncontrolled Keywords:

Akt, cancer, clinical trials, mTOR, phosphoinositide 3-kinase

BORIS DOI:

10.7892/boris.62498

URI:

https://boris.unibe.ch/id/eprint/62498

Actions (login required)

Edit item Edit item
Provide Feedback